Back to trial detailsIntake questionnaire
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Applying to Stanford University - Stanford Cancer Institute · Stanford, California
Answer a few short questions to share with the research team.
0 of 3 answered